MiningGold
Regis Resources resumes Duketon operations except Rosemont process plant after fatality
The Rosemont process plant remains suspended, with no restart date or production-impact estimate disclosed in the Nov. 9 update.
OzAurum Resources lifts Mulgabbie North gold resource to 294,000 ounces
The maiden Cross Fault estimate adds 34,000 ounces to inventory for the Western Australian project's heap-leach scoping study.
MiningCopper
FireFly Metals extends Green Bay core with 16.4 metres at 9.2% CuEq
A resource update and feasibility study are due by March 2027, following drilling above and outside the current resource.
Analysis
Diablo Resources reports 1,580 g/t silver in Horn grab samples
Historical mine-dump material also returned 0.47 per cent antimony as the Utah explorer ranks targets for drilling in early 2027.
Health
NASDAQ: MLYSMineralys Therapeutics reports 48‑week blood-pressure reduction
Lorundrostat's extension study showed a 17.8 mmHg reduction from baseline as an FDA decision approaches on Dec. 22.
Stock NewsAnalysis
Gold ETF inflows slow to US$2.7B in October as holdings hit record
European and Asian buying offset North American withdrawals, but lower gold prices cut global fund assets by 6 per cent.
HealthScience and Research
Vir Biotechnology meets Phase 3 hepatitis delta endpoint with 44% response
The delayed-treatment arm recorded no responses, while Vir plans an FDA submission in mid-2027 after two further pivotal readouts.
Health
NYSE: JNJAt week 16, 58 per cent achieved the main joint response versus 41 per cent on placebo; the oral drug is not approved for psoriatic arthritis.
Health
NASDAQ: BIAFNine-month CyPath Lung revenue rose 79 per cent, while quarterly company revenue fell and Sept. 30 cash stood at US$2.6 million.
Analysis
Cabaletta Bio reports year-long rese‑cel responses in six myositis patients
New Phase 1/2 data cover durability across three autoimmune diseases and safety in 71 patients treated after preconditioning.
Latest
PPL Corporation outlines US$5B to US$7B QTS power plan, raises growth target
The nonbinding terms cover about 2 gigawatts, while the regulated capital plan requires US$3 billion in additional equity.
Vistra reports US$2.38B adjusted EBITDA and sets 2027 outlook
The generator forecasts US$4.3B to US$5.1B in adjusted free cash flow before growth, with acquisition payments reducing liquidity.
BitFuFu reports 137 bitcoin mined in October as holdings increase
Self-mining output fell to 67 bitcoin from 98 in September, while cloud-mining production was almost unchanged.
Canopy Growth reports C$81.4M revenue as quarterly loss widens
Free cash outflow narrowed to C$15.5 million as international sales grew, while charges on Canopy USA assets weighed on earnings.
Cresco Labs reports US$172.8M revenue and US$26M operating cash flow
Quarterly losses narrowed, but operating income fell and September-end financial statements show US$41.2 million in cash plus restricted funds.
TeraWulf reports US$76.2M revenue as HPC leases dominate sales
Lease revenue reached US$63 million, but a non-cash warrant adjustment boosted profit and Justified still faces project financing.
Mentioned this week
Mining & Critical Minerals
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
Stock NewsAnalysis
China adds 25.8 tonnes of gold in October as reserve value falls
Official holdings rose to 78.30 million ounces, while their dollar valuation declined, separating physical demand from the value of the stockpile.
More in Mining
Health & Science
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
Health
TSE: MSCLMRI-measured muscle fat fraction replaces dynamometry in the 53-boy Duchenne study, with placebo-controlled data expected in Q1 2027.
Markets & Technology
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
Stock NewsAnalysis
Nasdaq‑100 selloff erases US$2.3T as technology shares slide
Nvidia closed 9.26 per cent lower as Bloomberg reported that trend-following funds amplified the Nov. 5 decline.
Technology
NASDAQ: ASSTStrive reports US$285.4M cash as preferred financing expands
Preferred equity sits outside reported liabilities, while unrealized bitcoin gains drove the third-quarter profit.
Energy
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
Energy
NYSE: MDUElectric utility earnings rose, while MDU narrowed Bakken East's estimated capital investment to US$2.8B to US$3.1B.
Energy
NASDAQ: MARAThe buyer expects closing in the coming weeks and says future computing demand would be supported by additional generation.
Energy
NYSE: DTEThe planned sale excludes EES Coke, while DTE’s 2027 earnings baseline assumes a closing earlier than the announced target.
Cannabis & Psychedelics
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
Cannabis
NASDAQ: VFFThe proposed common stamp would reduce the number of stamp types from 13 to six, with a Jan. 1, 2028 start date and no company savings estimate.
Cannabis
TSE: CRONQuarter-end cash, restricted cash and deposits totalled US$840.6 million before the October CanAdelaar acquisition.
Cannabis
NYSE: TRLVMedical-only quarterly results limit year-over-year comparisons as Trulieve reports a US$65 million mortgage repayment after September.
Cannabis
NASDAQ: RYMCash reached US$48.2 million as licensing supported operations, while approaching hemp restrictions threaten current products.